Advanced Drug Delivery Systems Global Market Overview 2024-2030 | Lipid-Based Carriers and Nanoparticles Drive Growth in mRNA, Gene Therapies, and Personalized Medicine Amid Chronic Disease Burden - ResearchAndMarkets.com

The "Advanced Drug Delivery Systems - A Global Market Overview" has been added to ResearchAndMarkets.com's offering.

The global ADDS market, valued at $277 billion in 2024, is anticipated to expand at a CAGR of 6.1%, amassing $394.5 billion by 2030.

This report provides an in-depth analysis of the global ADDS market, encompassing routes of administration, vehicle types, and application sectors from 2021-2030, with projections through 2030. It includes profiles of leading companies and recent industry developments to highlight market trends.

The integration of lipid-based carriers has proven critical for mRNA vaccines, and gene delivery techniques hold promise for genetic and rare disorders. This sector's innovation fosters personalized and efficient therapies, reshaping contemporary medicine. Escalating chronic diseases, tech advancements, and the surge in personalized medicine demand drive this growth. Notably, nanoparticles facilitate precise treatments for oncology, cardiovascular, and neurological ailments, while biologics and gene therapies create novel treatment avenues.

Advanced Drug Delivery Systems (ADDS) are integral in precision medicine, allowing for optimized release, absorption, and targeting of therapeutic agents. These technologies advance drug solubility, bioavailability, and effectiveness, while decreasing side effects and dosing frequency, thus improving patient adherence and outcomes. Employing carriers like nanoparticles, monoclonal antibodies, and liposomes, ADDS facilitates precise medication delivery. Methods such as oral, injectable, inhalation, and implantable devices provide versatile solutions for various medical scenarios. Transdermal patches and bioadhesive formulations further cater to specialized clinical needs.

Advanced Drug Delivery Systems (ADDS) Regional Market Analysis

North America leads the ADDS market, commanding a 39.5% share in 2024 due to a robust pharmaceutical industry and substantial healthcare investments. The U.S. pioneers this domain, benefiting from injectable advancements and increasing chronic disease cases. Conversely, the Asia-Pacific region is poised for rapid growth, with a projected 7.6% CAGR from 2024 to 2030. Government-backed healthcare investments and an expanding clinical research landscape in China, India, and Japan fuel this momentum.

Advanced Drug Delivery Systems (ADDS) Market Analysis by Route of Administration

The oral route dominates the ADDS market, capturing over 36% in 2024 due to its convenience and cost-effectiveness, especially in chronic disease management. Innovations in nanotechnology and controlled-release formulations enhance this segment. The injectable route is the fastest-growing, with a projected 6.9% CAGR from 2024-2030, driven by biologics, cell, and gene therapies. Advances in self-injection devices and long-acting injectables boost this segment's growth.

Advanced Drug Delivery Systems (ADDS) Market Analysis by Vehicle/Carrier Type

Nanoparticles dominate the ADDS market, holding a 32% share in 2024. They are pivotal in improving drug solubility and enabling targeted delivery in oncology and infectious disease treatments. Monoclonal antibodies represent the fastest-growing segment, with an 8% CAGR from 2024-2030, driven by innovations in cancer and autoimmune disorder treatments. The development of bispecific antibodies and ADCs broadens therapeutic options, propelling growth in this segment.

Advanced Drug Delivery Systems (ADDS) Market Analysis by Application

Oncology leads the ADDS application market, holding a 23.4% share in 2024. The increasing global cancer burden drives demand for targeted therapies that minimize side effects. In contrast, the neurology segment is set to record the fastest CAGR of 6.7% from 2024-2030, fueled by rising neurological disease cases and advancements in blood-brain barrier penetration and gene therapies.

Key Attributes:

Companies Featured

• Abbott Laboratories, Inc.
• AbbVie, Inc.
• Adare Pharmaceuticals, Inc
• Alkermes, Inc.
• Amgen, Inc.
• AptarGroup, Inc.
• AstraZeneca plc
• Baxter International Inc.
• Bayer AG
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Bristol-Myers Squibb Company
• Catalent, Inc.
• Elixir Medical Corporation
• Evonik Industries AG
• F. Hoffmann-La Roche AG
• Gerresheimer AG
• Hisamitsu Pharmaceutical Co., Inc.
• HNS International, Inc.
• Insulet Corporation
• Johnson & Johnson
• Kindeva Drug Delivery L.P.
• Lonza Group AG
• Medtronic plc
• Novartis AG
• Novavax, Inc.
• Pfizer, Inc.
• Recipharm AB
• Serina Therapeutics, Inc.
• SHL Group
• Stevanato Group
• Terumo Corporation
• Teva Pharmaceutical Industries Ltd.
• Vetter Pharma International GmbH
• West Pharmaceutical Services, Inc.
• Ypsomed Holding AG

Key Metrics

• Historical Period: 2021-2023
• Base Year: 2024
• Forecast Period: 2024-2030
• Units: Value market in US$
• Companies Mentioned: 30+

Advanced Drug Delivery Systems (ADDS) Market by Route of Administration

• Oral
• Injectable/Parenteral
• Inhalation/Pulmonary
• Transmucosal
• Implantable Systems
• Others (Topical, Transdermal, Ocular & Otic, Targeted Delivery, Bioadhesive, Hybrid Systems)

Advanced Drug Delivery Systems (ADDS) Market by Vehicle/Carrier Type

• Nanoparticles
• Monoclonal Antibodies
• Liposomes
• Polymeric NPs
• Prodrugs
• Microparticles
• Other Vehicle/Carrier Types (Hydrogels, Implants, Viral Vectors, Dendrimers)

Advanced Drug Delivery Systems (ADDS) Market by Application

• Oncology
• Cardiology
• Neurology
• Pulmonary
• Ophthalmic
• Infectious Diseases
• Inflammatory Diseases and Allergies
• Other Applications (Diabetes, Urology, GI Disorders, Dermatology, Hormone Replacement Therapy, Gynecology)

For more information about this report visit https://www.researchandmarkets.com/r/vgwbib

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250703048724/en/